Form 4: OptiNose CFO Terry Kohler Reports Stock and Option Awards
SEC Form 4 Filing
Chief Financial Officer of OptiNose, Terry Kohler, reports the acquisition of restricted stock units and stock options, according to a Form 4 filing with the SEC.
Summary
- Terry Kohler, the CFO of OptiNose, Inc., filed a Form 4 with the SEC.
- The filing reports the grant of 13,875 restricted stock units (RSUs) on February 21, 2025, which vest over four years.
- 25% of the RSUs vest on February 21, 2026, with the remainder vesting in equal quarterly installments over the following three years, contingent upon continued service.
- Each RSU represents the right to receive one share of OptiNose common stock.
- Kohler also received a stock option to purchase 6,950 shares at an exercise price of $5.77 on February 21, 2025.
- The options also vest over a four-year period, with 25% vesting on February 21, 2026, and the balance vesting in equal monthly installments over the remaining three years, subject to continued service.
- All share numbers reflect a 1-for-15 reverse stock split that OptiNose implemented on December 30, 2024.
- Following the reported transactions, Kohler directly owns 23,875 shares of common stock and options to purchase 6,950 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The filing reflects standard compensation practices and aligns management interests with shareholders. There are no indications of negative events or concerns.
Positives
- The grant of RSUs and stock options to the CFO aligns his interests with those of the shareholders.
- The vesting schedules incentivize continued service with the company.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The grants are a common way to compensate and incentivize key executives.
Stakeholder Impact
- The grants align the CFO's interests with shareholders, potentially leading to better performance.
- Employees may view the grants as a positive sign of company stability and growth.
Key Dates
| Date | Description |
|---|---|
| 12/30/2024 | 1-for-15 reverse stock split effected by the Company |
| 02/21/2025 | Date of earliest transaction (grant of RSUs and stock options) |
| 02/21/2026 | First vesting date for 25% of RSUs and stock options |
| 02/21/2035 | Expiration date of stock options |
| 02/26/2025 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.